Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
0.6700
-0.0070 (-1.03%)
Aug 6, 2026, 9:43 AM EDT - Market open

Inovio Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.070.220.8310.261.77
Revenue Growth
--69.99%-73.83%-91.89%478.24%-76.05%
Gross Profit
00.070.220.8310.261.77
Operating Income
-83.72-86.82-112.4-143.94-267.57-301.22
Net Income
-84.93-84.95-107.25-135.12-279.82-303.66
Earnings Per Share
-1.45-1.81-3.95-6.09-14.07-17.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37.6858.5194.11145.29253401.31
Total Debt
8.79.3711.8730.2132.0733.02
Net Cash (Debt)
28.9949.1482.25115.08220.92368.29
Net Cash Growth
-49.23%-40.25%-28.53%-47.91%-40.01%-1.16%
Net Cash Per Share
0.521.053.035.1911.1121.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-83.35-88.63-104.08-124.37-216.22-215.71
Capital Expenditures
-0.23-0.29-0.49-0.32-0.97-1.23
Free Cash Flow
-83.57-88.92-104.56-124.69-217.18-216.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--132871.00%-51616.90%-17300.30%-2607.35%-16972.30%
Pretax Margin
--130000.00%-49254.27%-16239.87%-2726.67%-17109.87%
Profit Margin
--130000.00%-49254.30%-16239.90%-2726.67%-17109.90%
FCF Margin
--136074.00%-48019.10%-14986.20%-2116.34%-12223.60%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1837.29303.38167.3338.47611.21